Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Fat tissue under the skin affects hair growth and aging; reducing its inflammation may help treat hair loss.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

Certain fungi protect skin health, but changes can allow harmful fungi to cause serious infections, needing more research for treatment and control.